Malignant pericardial effusion: Sclerotherapy or local chemotherapy

British Journal of Cancer

Volumn 101, Issue 4, 2009, Pages 734-735

  Lestuzzi, C ^a   Lafaras, C ^b   Bearz, A ^a   Gralec, R ^c   Viel, E ^a   Buonadonna, A ^a   Bischiniotis, T ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; PLATINUM;

DRUG EFFECT; DRUG EFFICACY; HUMAN; KIDNEY FAILURE; LETTER; LUNG CANCER; MALIGNANT PERICARDIAL EFFUSION; METASTASIS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; THORAX PAIN;

ANTINEOPLASTIC AGENTS; BLEOMYCIN; HUMANS; LUNG NEOPLASMS; PERICARDIAL EFFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCLEROTHERAPY;

EID: 68749109285     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605108     Document Type: Letter

References (11)

1. Bischiniotis TS, Lafaras CTh, Platogiannis DN, Moldovan L, Barbetakis NG, Katseas GP (2005) Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade. Hell J Cardiol 46: 324-329
2. D'Addario G, Felip E (2008) Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19: ii39-ii40
3. Figoli F, Zanette ML, Tirelli U, Sorio R, Lestuzzi C, Urso R, Monfardini S, D'Incalci M (1987) Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion. Cancer Chemother Pharmacol 20: 239-242
4. Kunitoh H, Tamura T, Shibata T, Imai M, Nishiwaki Y, Nishio M, Yokoyama A, Watanabe K, Noda K, Saijo N (2009) A randomized trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer 100: 464-469
5. Lestuzzi C, Viel E, Sorio R, Meneguzzo N (2000) Local chemotherapy for neoplastic pericardial effusion. Am J Cardiol 86: 1292
6. Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R. (2002) Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23: 1625-1631
7. Martinoni A, Cipolla CM, Cardinale D, Civelli M, Lamantia G, Colleoni M, Fiorentini C (2004) Long-term results of intrapericardial chemo-therapeutic treatment of malignant pericardial effusions with thiotepa. Chest 126: 1412-1416
8. Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999) Pericardioscopy for primary management of pericardial effusion in cancer patients. Eur J Cardiothorac Surg 16: 287-291
9. Reynen K, Koeckeritz U, Strasser RH (2004) Metastases to the heart. Ann Oncol 15: 375
10. Tomkowski WZ, Wisniewska J, Szturmowicz M, Kuca P, Burakowski J, Kober J, Fijalkowska A (2004) Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 12: 53-57
11. Wang PC, Yang KY, Chao JY, Ming Liu J, Perng RP, Yen SH (2000) Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 118: 744-749